secwatch.observer — SEC 8-K summary
======================================

Issuer:     Calithera Biosciences, Inc. (—)
CIK:        0001496671
Form:       8-K
Filed at:   2023-01-25T23:59:59+00:00
Accession:  0001193125-23-014684
Event type: other_material
Sentiment:  negative
Materiality: 1.00
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Calithera to dissolve; Nasdaq delisting effective Feb 2, 2023 after 'public shell' determination
--------------------------------------------------------------------------------

- Board approved dissolution and liquidation plan on Jan 9, 2023, subject to stockholder approval.
- Company discontinuing all clinical programs and terminating most employees by end of Q1.
- Nasdaq notified Calithera it is a 'public shell'; company will not appeal the determination.
- Trading of common stock to be suspended as of Feb 2, 2023; Nasdaq to file Form 25-NSE to delist.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1496671/000119312523014684/0001193125-23-014684-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1496671/000119312523014684/d181884d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-014684

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer